1460879941-d0c66ea8-3d3b-449a-bb84-56c8e2b3d939

1. A human cytomegalovirus (hCMV) Intron A fragment, wherein said fragment lacks the full-length Intron A sequence and comprises: (a) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 1-25, inclusive, of FIG. 1A, and (b) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 775-820, inclusive, of FIG. 1A, wherein when said fragment is present in an expression construct, the expression construct achieves expression levels greater than those levels achieved by a corresponding construct that completely lacks an Intron A sequence.
2. The Intron A fragment of claim 1, wherein said fragment comprises: (a) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 1-51, inclusive, of FIG. 1A, and (b) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 741-820, inclusive, of FIG. 1A, wherein when said fragment is present in an expression construct, the expression construct achieves expression levels greater than those levels achieved by a corresponding construct that completely lacks an Intron A sequence.
3. The Intron A fragment of either of claim 1 or 2, wherein when said fragment is present in an expression construct, the expression construct achieves expression levels at least two-fold greater than those levels achieved by a corresponding construct that completely lacks an Intron A sequence.
4. The Intron A fragment of either of claim 1 or 2, wherein when said fragment is present in an expression construct, the expression construct achieves expression levels at least ten-fold greater than those levels achieved by a corresponding construct that completely lacks an Intron A sequence.
5. The Intron A fragment of either of claim 1 or 2, wherein when said fragment is present in an expression construct, the expression construct achieves expression levels at least fifty-fold greater than those levels achieved by a corresponding construct that completely lacks an Intron A sequence.
6. The Intron A fragment of claim 2, wherein said fragment comprises the sequence of nucleotides 1-51, inclusive, of FIG. 1A, linked to nucleotides 741-820, inclusive, of FIG. 1A.
7. The Intron A fragment of claim 2, wherein said fragment comprises the Intron A nucleotide sequence depicted in FIG. 1C, or a nucleotide sequence with at least about 75% sequence identity thereto.
8. The Intron A fragment of claim 7, wherein said fragment consists of the Intron A nucleotide sequence depicted in FIG. 1C.
9. A human cytomegalovirus (hCMV) Intron A fragment, wherein said fragment lacks the full-length Intron A sequence and comprises: (a) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 1-25, inclusive, of FIG. 1A, and (b) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 775-820, inclusive, of FIG. 1A, wherein when said fragment is present in an expression construct, the expression construct achieves expression levels equal to, or greater than, those levels achieved by an expression construct that includes a corresponding intact, full-length Intron A sequence.
10. A human cytomegalovirus (hCMV) Intron A fragment, wherein said fragment lacks the full-length Intron A sequence and comprises: (a) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 1-51, inclusive, of FIG. 1A, and (b) a sequence of nucleotides having at least about 75% sequence identity to the contiguous sequence of nucleotides found at positions 741-820, inclusive, of FIG. 1A, wherein when said fragment is present in an expression construct, the expression construct achieves expression levels equal to, or greater than, those levels achieved by an expression construct that includes a corresponding intact, full-length Intron A sequence.
11. A recombinant expression construct effective in directing the transcription of a selected coding sequence, said expression construct comprising:
(a) a coding sequence;
(b) control elements that are operably linked to said coding sequence, wherein said control elements comprise the Intron A fragment of any of claims 1-10,
whereby said coding sequence can be transcribed and translated in a host cell.
12. The recombinant expression construct of claim 11, wherein said control elements further comprise a promoter selected from the group consisting of an SV40 early promoter, a CMV promoter, a mouse mammary tumor virus LTR promoter, an adenovirus major late promoter, an RSV promoter, a SR\u03b1 promoter, and a herpes simplex virus promoter.
13. The recombinant expression construct of claim 11, wherein said control elements further comprise the hCMV immediate-early (IE1) enhancerpromoter region found at nucleotide positions 460 to 1264 of FIG. 2, and said control elements further comprise Exon 2 of the 5\u2032-UTR comprising the sequence of nucleotides depicted at positions 821-834, inclusive, of FIG. 1A.
14. A host cell comprising the recombinant expression construct of any of claims 11-13.
15. A method of producing a recombinant polypeptide comprising:
(a) providing a population of host cells according to claim 14; and
(b) culturing said population of cells under conditions whereby said coding sequence of said recombinant expression construct is expressed, thereby producing said recombinant polypeptide.
16. A method of producing a recombinant polypeptide comprising:
(a) introducing the expression construct of any of claims 11-13 into a host cell; and
(b) causing expression of the coding sequence of said expression construct to produce the recombinant polypeptide.
17. A polynucleotide comprising the sequence depicted in FIG. 5B.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A one-piece cast piston comprising a body member with a crown, a central cavity, an integral internal coolant gallery passageway, and a plurality of extension chambers connected to and extending from said passageway, at least one coolant feeddrain passage connecting said central cavity to said coolant gallery passageway, and said chambers being blind ended and formed in the piston when it is cast, wherein localized coolant flow is provided and a greater coolant surface contact area inside said body member is provided.
2. The one-piece cast piston as recited in claim 1 wherein said coolant gallery piston comprises an annular ring.
3. The one-piece cast piston as recited in claim 2 wherein said extension chambers are equally spaced around the circumference of said annular ring.
4. The one-piece cast piston as recited in claim 3 wherein said extension chambers are spaced between 12\xb0-24\xb0 apart and there are between 15-30 extension chambers provided.
5. The one-piece cast piston as recited in claim 2 wherein said annular ring shaped coolant gallery passageway has a diameter of about 70% of the diameter of the piston.
6. The one-piece cast piston as recited in claim 2 wherein said extension chambers have a height of between 50%-150% of the diameter of said annular ring.
7. The one-piece cast piston as recited in claim 1 wherein said piston has a longitudinal axis and said extension chambers are orientated substantially parallel to said longitudinal axis.
8. The one-piece cast piston as recited in claim 1 wherein said blind ends of said extension chambers have a curved profile.
9. The one-piece cast piston as recited in claim 1 wherein said blind ends of said extension chambers have generally tapered cross-sections.
10. The one-piece cast piston as recited in claim 1 wherein said blind ends of said extension chamber have generally conical cross-sections.
11. The one-piece cast piston as recited in claim 1 wherein said piston has a longitudinal axis and said fooddrain passageways are positioned substantially parallel to said longitudinal axis.
12. The one-piece cast piston as recited in claim 1 wherein said coolant gallery passageway comprises a open curved shaped annulus.
13. The one-piece cast piston as recited in claim 1 wherein said coolant gallery passageway has a generally circular cross-section.
14. The one-piece cast piston as recited in claim 1 wherein the spacing between said extension chambers is substantially the same as the width of said extension chambers.
15. The one-piece cast piston as recited in claim 1 wherein said piston has a longitudinal axis and at least one group of extension chambers are positioned extending in a direction toward said piston crown and at least a second group of extension chambers are positioned extending in a direction away from said piston crown and toward said central cavity.
16. A reciprocating piston-in-cylinder internal combustion engine incorporating at least one piston as set forth in claim 1.
17. A one-piece cast piston having a crown and a longitudinal axis comprising a body member with an annular shaped integral internal coolant gallery passageway and a plurality of connected extension chambers, said extension chambers being blind ended, being substantially equally spaced around the circumference of said passageway and extending in a direction substantially parallel to said longitudinal axis.
18. A one-piece cast piston as recited in claim 17 wherein at least a portion of said extension chambers extend in a direction other than toward said crown of said piston.
19. A one-piece cast piston as recited in claim 17 wherein said extension chambers have a profile selected from the group consisting of curved, tapered and conical.
20. The one-piece cast piston as recited in claim 17 wherein said passageway has a substantially circular cross-section and a diameter about 70% of the diameter of the piston, and said extension chambers have a length of between 50-150% of the diameter of said passageway.